Meyka Pro banner
Enovis Corporation

Enovis Corporation Fundamental Analysis (NYSE: ENOV)

ENOV●NYSE
HealthcareMedical - Devices
$28.54
$1.38(5.08%)
U.S. Market opens in 15h 50m

Enovis Corporation Fundamental Analysis (NYSE: ENOV)

Enovis Corporation (NYSE: ENOV) shows moderate financial fundamentals with a PE ratio of -2.93, profit margin of -22.87%, and ROE of -35.53%. The company generates $2.3B in annual revenue with moderate year-over-year growth of 6.66%.

Key Strengths

PEG Ratio-0.04
Current Ratio2.15

Areas of Concern

ROE-35.53%
Operating Margin3.87%
Cash Position3.97%
We analyze ENOV's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -23.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-23.2/100

We analyze ENOV's fundamental strength across five key dimensions:

Efficiency Score

Weak

ENOV struggles to generate sufficient returns from assets.

ROA > 10%
-14.12%

Valuation Score

Excellent

ENOV trades at attractive valuation levels.

PE < 25
-2.93
PEG Ratio < 2
-0.04

Growth Score

Moderate

ENOV shows steady but slowing expansion.

Revenue Growth > 5%
6.66%
EPS Growth > 10%
-39.72%

Financial Health Score

Excellent

ENOV maintains a strong and stable balance sheet.

Debt/Equity < 1
0.90
Current Ratio > 1
2.15

Profitability Score

Weak

ENOV struggles to sustain strong margins.

ROE > 15%
-3553.41%
Net Margin ≥ 15%
-22.87%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is ENOV Expensive or Cheap?

P/E Ratio

ENOV trades at -2.93 times earnings. This suggests potential undervaluation.

-2.93

PEG Ratio

When adjusting for growth, ENOV's PEG of -0.04 indicates potential undervaluation.

-0.04

Price to Book

The market values Enovis Corporation at 1.05 times its book value. This may indicate undervaluation.

1.05

EV/EBITDA

Enterprise value stands at -1.46 times EBITDA. This is generally considered low.

-1.46

How Well Does ENOV Make Money?

Net Profit Margin

For every $100 in sales, Enovis Corporation keeps $-22.87 as profit after all expenses.

-22.87%

Operating Margin

Core operations generate 3.87 in profit for every $100 in revenue, before interest and taxes.

3.87%

ROE

Management delivers $-35.53 in profit for every $100 of shareholder equity.

-35.53%

ROA

Enovis Corporation generates $-14.12 in profit for every $100 in assets, demonstrating efficient asset deployment.

-14.12%

Following the Money - Real Cash Generation

Operating Cash Flow

Enovis Corporation produces operating cash flow of $259.01M, showing steady but balanced cash generation.

$259.01M

Free Cash Flow

Enovis Corporation produces free cash flow of $69.56M, offering steady but limited capital for shareholder returns and expansion.

$69.56M

FCF Per Share

Each share generates $1.21 in free cash annually.

$1.21

FCF Yield

ENOV converts 4.41% of its market value into free cash.

4.41%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.93

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.05

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.68

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.90

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.15

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.36

vs 25 benchmark

ROA

Return on assets percentage

-0.14

vs 25 benchmark

ROCE

Return on capital employed

0.03

vs 25 benchmark

How ENOV Stacks Against Its Sector Peers

MetricENOV ValueSector AveragePerformance
P/E Ratio-2.9330.84 Better (Cheaper)
ROE-35.53%573.00% Weak
Net Margin-22.87%5349.00% Weak
Debt/Equity0.90-0.03 (disorted) Distorted
Current Ratio2.155.76 Strong Liquidity
ROA-14.12%-254.00% (disorted) Weak

ENOV outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Enovis Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

61.02%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-2330.59%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-42.23%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ